BeStock  

Church & Dwight CHD

US equityMarket cap rank #742Household & Personal Products
$110.84 +$1.16 (+1.06%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $110.84 0.00%
Open$110.69
Prev close$109.68
Day range$110.31 – $111.92
Volume2.10M
Market cap$26.16B
P/E (TTM)34.0
Dividend yield1.10%

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$1.60B+1.0% YoY
Operating profit$291.40M+14.5% YoY
Net profit$212.20M+16.5% YoY
Diluted EPS$0.89+18.7% YoY
Free cash flow$349.80M-14.1% YoY
Operating cash flow$379.60M

Revenue, last 8 quarters

$1.6BDec '24$1.5BMar '25$1.5BJun '25$1.6BSep '25$1.6BDec '25$1.5BMar '26$1.5BJun '26$1.6BSep '26

Net profit, last 8 quarters

$189.2MDec '24$220.1MMar '25$191.0MJun '25$182.2MSep '25$143.5MDec '25$216.3MMar '26$202.8MJun '26$212.2MSep '26

Diluted EPS by quarter

0.76Dec '240.89Mar '250.78Jun '250.75Sep '250.60Dec '250.91Mar '260.85Jun '260.89Sep '26

Free cash flow by quarter

$237.7MDec '24$169.2MMar '25$208.3MJun '25$407.3MSep '25$308.2MDec '25$142.9MMar '26$256.9MJun '26$349.8MSep '26

Annual revenue

$4.9BFY20$5.2BFY21$5.4BFY22$5.9BFY23$6.1BFY24$6.2BFY25

Profitability & balance sheet

Gross margin46.1%
Operating margin18.0%
Net margin12.4%
Return on equity17.8%
Return on assets8.4%
Return on invested capital12.5%
Current ratio0.96
Liabilities / assets52.0%
Cash & investments$446.90M
Total debt$2.21B
Net cash (debt)-$1.76B
Free cash flow / sales16.9%

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Consumer Domestic$1.23B 76.5%
  • Consumer International$297.40M 18.6%
  • Specialty Products Division (SPD)$79.60M 5.0%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $1.60B $1.53B $1.47B $6.20B $1.64B
Total Operating Revenue $1.60B $1.53B $1.47B $6.20B $1.64B
Cost of Revenue $852.70M $836.10M $787.90M $3.43B $890.40M
Gross Profit $749.40M $693.90M $681.40M $2.77B $753.80M
Operating Expense $458.00M $417.50M $390.40M $1.70B $487.80M
Selling and Admin Expenses $458.00M $417.50M $390.40M $1.70B $487.80M
-Selling & Marketing Expense $190.70M $165.30M $139.40M $708.90M $212.30M
-General & Admin Expense $267.30M $252.20M $251.00M $988.30M $275.50M
Operating Profit $291.40M $276.40M $291.00M $1.08B $266.00M
Net Non-Operating Interest Income (Expense) -$21.40M -$22.80M -$21.50M -$71.70M -$22.50M
Non-Operating Interest Income $2.70M $1.40M $2.50M $23.50M $2.10M
Non-Operating Interest Expense $24.10M $24.20M $24.00M $95.20M $24.60M
Other Income (Expense) $1.90M $2.30M $3.10M -$49.00M -$55.40M
Earnings from Equity Interest $2.70M $2.70M $2.30M $7.90M $1.30M
Other Non-Operating Income (Expenses) -$800,000.00 -$400,000.00 $800,000.00 -$56.90M -$56.70M
Pretax Profit $271.90M $255.90M $272.60M $956.90M $188.10M
Tax $59.70M $53.10M $56.30M $220.10M $44.60M
Net Profit $212.20M $202.80M $216.30M $736.80M $143.50M
Profit from Continuing Operations $212.20M $202.80M $216.30M $736.80M $143.50M
Net Income to Parent Company $212.20M $202.80M $216.30M $736.80M $143.50M
Net Income to Common Stockholders $212.20M $202.80M $216.30M $736.80M $143.50M
Basic EPS $0.89 $0.86 $0.91 $3.04 $0.60
Diluted EPS $0.89 $0.85 $0.91 $3.02 $0.60
Dividend Per Share $0.31 $0.31 $0.31 $1.18 $0.30
Special Income (Charges) – – – $0.00 $0.00
-Less:Impairment of Capital Assets – – – $0.00 $0.00

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $9.34B $9.11B $9.01B $8.91B $8.91B
Total Current Assets $1.77B $1.52B $1.72B $1.60B $1.60B
Cash and Cash Equivalents & Short-Term Investments $446.90M $254.80M $503.40M $409.00M $409.00M
-Cash and Cash Equivalents $446.90M $254.80M $503.40M $409.00M $409.00M
Receivables $635.20M $596.80M $576.60M $593.40M $593.40M
-Accounts Receivable $635.20M $596.80M $576.60M $593.40M $593.40M
Inventory $632.30M $601.90M $578.40M $534.80M $534.80M
Other Current Assets $58.00M $68.20M $62.30M $59.80M $59.80M
Total Non-Current Assets $7.57B $7.58B $7.29B $7.32B $7.32B
Net PPE $834.80M $826.50M $823.90M $822.80M $822.80M
-Gross PPE $1.76B $1.74B $1.72B $1.70B $1.70B
-Accumulated Depreciation -$923.30M -$912.90M -$892.30M -$874.20M -$874.20M
Investments and Advances $11.90M $12.10M $12.30M $10.30M $10.30M
-Long Term Equity Investment $11.90M $12.10M $12.30M $10.30M $10.30M
Goodwill and Other Intangible Assets $6.37B $6.39B $6.11B $6.14B $6.14B
-Goodwill $2.67B $2.65B $2.63B $2.63B $2.63B
-Other Intangible Assets $3.71B $3.74B $3.48B $3.51B $3.51B
Other Non-Current Assets $348.10M $352.40M $343.00M $343.30M $343.30M
Total Liabilities $4.85B $4.76B $4.82B $4.91B $4.91B
Total Current Liabilities $1.85B $1.33B $1.41B $1.50B $1.50B
Payables $850.90M $780.80M $763.50M $735.80M $735.80M
-Accounts Payable $806.10M $775.90M $729.90M $732.40M $732.40M
-Total Tax Payable $44.80M $4.90M $33.60M $3.40M $3.40M
Current Accrued Expenses $576.30M $481.90M $649.90M $761.90M $761.90M
Short-Term Debt and Capital Lease Obligation $424.70M $49.90M – – –
-Current Debt $424.70M $49.90M – – –
Total Non-Current Liabilities $3.00B $3.43B $3.41B $3.41B $3.41B
Long Term Debt and Capital Lease Obligation $1.78B $2.21B $2.21B $2.21B $2.21B
-Long Term Debt $1.78B $2.21B $2.21B $2.21B $2.21B
Non-Current Deferred Liabilities $894.60M $894.10M $891.60M $886.90M $886.90M
Other Non-Current Liabilities $326.20M $330.30M $309.80M $320.50M $320.50M
Total Equity $4.48B $4.35B $4.19B $4.00B $4.00B
Stockholders' Equity $4.48B $4.35B $4.19B $4.00B $4.00B
Capital Stock $294.00M $293.70M $293.70M $293.70M $293.70M
-Common Stock $294.00M $293.70M $293.70M $293.70M $293.70M
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $702.30M $676.90M $654.10M $625.10M $625.10M
Retained Earnings $7.18B $7.04B $6.91B $6.77B $6.77B
Less: Treasury Stock -$3.68B -$3.65B -$3.66B -$3.66B -$3.66B
Gains/Losses Not Affecting Retained Earnings -$12.90M -$14.50M -$16.60M -$19.90M -$19.90M
Other Current Liabilities – $14.60M – – –

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $379.60M $286.80M $174.80M $1.22B $363.40M
Net cash flow from continuing operations $379.60M $286.80M $174.80M $1.22B $363.40M
Net Income from Continuing Operations $212.20M $202.80M $216.30M $736.80M $143.50M
Gain/Loss from Continuing Operations -$2.70M -$2.70M -$2.30M $50.60M $57.20M
Depreciation & Depletion & Amortization $65.60M $64.30M $62.90M $247.40M $65.80M
Deferred Tax $0.00 -$100,000.00 $4.50M $36.00M $4.30M
Other Non-Cash Items $500,000.00 $5.30M -$200,000.00 $12.30M -$1.70M
Change in Working Capital $83.10M -$1.00M -$134.00M $9.80M $73.80M
-Change in Receivables -$40.00M -$19.60M $13.70M $39.40M $21.90M
-Change in Inventory -$32.80M -$20.30M -$45.10M $56.10M $59.40M
-Change in Payables and Accrued Expense $157.00M $43.30M -$84.80M -$63.60M -$6.70M
-Change in Other Current Assets $8.00M -$3.80M -$8.30M $1.20M -$500,000.00
-Change In Other Working Capital -$9.10M -$600,000.00 -$9.50M -$23.30M -$300,000.00
Net cash flow from investing -$40.80M -$328.40M -$33.50M -$616.90M $108.40M
Net Cash Flow from Continuing Investing Activities -$40.80M -$328.40M -$33.50M -$616.90M $108.40M
Net PPE Purchase and Sale -$29.80M -$29.90M -$31.90M -$122.40M -$55.20M
Net Business Purchase and Sale -$10.00M – – -$495.70M $160.70M
Net Other Investing Changes -$1.00M $1.50M -$1.60M $1.20M $2.90M
Financing Cash Flow -$146.20M -$206.80M -$44.90M -$1.16B -$368.50M
Net Cash Flow from Continuing Financing Activities -$146.20M -$206.80M -$44.90M -$1.16B -$368.50M
Net Common Stock Issuance -$37.10M – – -$900.00M -$300.00M
Cash Dividends Paid -$73.80M -$72.90M -$72.90M -$287.20M -$70.80M
Proceeds from Stock Option Exercised $16.10M $14.20M $16.60M $35.60M $2.50M
Net Other Financing Charges -$1.50M -$198.00M $11.40M -$10.80M -$200,000.00
Ending Cash Balance $446.90M $254.80M $503.40M $409.00M $409.00M
Net Change in Cash $192.60M -$248.40M $96.40M -$563.90M $103.30M
Beginning Cash Balance $254.80M $503.40M $409.00M $964.10M $305.30M
Effect of Exchange Rate Changes -$500,000.00 -$200,000.00 -$2.00M $8.80M $400,000.00
Free Cash Flow $349.80M $256.90M $142.90M $1.09B $308.20M
Net Issuance Payments Of Debt – – – $0.00 $0.00

Discussion

No comments yet — be the first to weigh in on CHD.

Sign in to join the discussion.

Scroll to Top